InvestorsHub Logo
Followers 1
Posts 256
Boards Moderated 0
Alias Born 08/19/2008

Re: None

Friday, 03/08/2013 12:26:27 PM

Friday, March 08, 2013 12:26:27 PM

Post# of 97239
JMP Securities NAVB update - Lymphoseek Approval Remains Key Catalyst - Market Outperform $6.00 Target




Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.